Horizon Pharma (HZNP) Misses Q3 Views; Revs Light
Tweet
Share
E-mailGet Alerts HZNP Hot Sheet
Join SI Premium – FREE
Horizon Pharma (NASDAQ: HZNP) reported Q3 EPS of ($1.18), $0.24 worse than the analyst estimate of ($0.94). Revenue for the quarter came in at $273 thousand versus the consensus estimate of $1.14 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
- Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
